Search Results - L. A. Balykova

Refine Results
  1. 1

    NEWBORNS OF HIGH RISK GROUPS AND ELECTROPHYSIOLOGICAL CARDIAC ACTIVITY DURING THE PERIOD OF EARLY ADAPTATION by T. S. Tumaeva, L. A. Balykova

    Published 2014-01-01

    Aim: to study characteristics of electrophysiological cardiac activity in children of risk groups and to assess possibilities of Holter-electrocardiography (H-ECG) in revealing of cardiac dysfunction during the period of early adaptation. Patients and methods: 250 newborns were examined. The main gr...

    Full description

    Get full text
    Article
  2. 2

    THE EXPERIENCE OF PNEUMOCOCCAL CONJUGATE VACCINE USAGE IN ORPHANAGE INSTITUTION OF THE REPUBLIC OF MORDOVIA by A. A. Brovkina, L. A. Balykova, N. B. Kulagina

    Published 2012-11-01

    The experience of pneumococcal vaccine usage in the inmates of the Orphanage for Children with Organic Central Nervous System with Psychic Disturbances is discussed in this article. Taking into account the high rate and severe course of acute pneumonia among such children, 120 dosages of pneumococca...

    Full description

    Get full text
    Article
  3. 3

    The COVID-19 pandemic: an analysis of the epidemic situation and the restructuring of medical education (according to the Republic оf Mordovia) by L. A. Balykova, L. F. Sabirov, E. V. Semeleva

    Published 2021-12-01

    The emergence of a new variant of the virus and the epidemic potential manifested by the causative agent of COVID-19 have set health professionals tasks related to the rapid development of diagnostics and prevention of a new infection, as well as tactics for providing medical care to patients. The a...

    Full description

    Get full text
    Article
  4. 4

    PROBLEM OF METABOLIC DISORDERS IN CHILDREN WITH JUVENILE ARTHRITIS LIVING IN THE REPUBLIC OF MORDOVIA by A. V. Krasnopolskaya, L. A. Balykova, T. I. Kornilova, A. A. Shirokova

    Published 2014-10-01

    It is assumed that juvenile idiopathic arthritis (JIA), as many other rheumatic diseases, is in close pathogenic connection with metabolic disorders and early atherosclerosis. However, the prevalence of metabolic syndrome and its components both in healthy Finno-Ugrian children and teens and JIA pat...

    Full description

    Get full text
    Article
  5. 5

    EFFICACY OF INFLIXIMAB IN PATIENT WITH UNFAVORABLE CLINICAL COURSE OF JUVENILE RHEUMATOID ARTHRITIS by L.A. Balykova, N.V. Ivyanskaya, T.I. Kornilova, A.V. Balykova

    Published 2011-05-01

    The article presents a case report of aggressive rapidly progressive severe polyarticular juvenile rheumatoid arthritis (JRA) resistant to standard immunosuppressive treatment. Patient with extra-early (up to 6 months) arthritis was successfully treated with genetically engineered biological agent i...

    Full description

    Get full text
    Article
  6. 6
  7. 7

    ABATACEPT IN TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS: INTERNATIONAL DATA AND EXPERIENCE OF USAGE IN THE REPUBLIC OF MORDOVIA by L. A. Balykova, N. V. Ivyanskaya, A. V. Krasnopol’skaya, P. A. Trupanova

    Published 2014-03-01

    The authors represent a review of modern views on abatacept usage in treatment of juvenile idiopathic arthritis emphasizing its high level of safety and possibility to use it in patients resistant to standard basic therapy and tumor necrosis factor alfa inhibitors. The results of clinical investigat...

    Full description

    Get full text
    Article
  8. 8

    ADALIMUMAB USAGE CASE IN A PATIENT WITH JUVENILE OLIGOARTHRITIS AND UVEITIS by L. A. Balykova, N. V. Ivyanskaya, T. N. Arzamaskina, E. V. Makarkina, Ya. V. Lavskaya

    Published 2013-11-01

    The article presents a case of a severe progressive course of a juvenile arthritis refractory to the standard antirheumatic therapy. Due to oligosymptomatic disease onset and low adherence of the patient to treatment, the disease was characterized by development of polyarticular joint syndrome with...

    Full description

    Get full text
    Article
  9. 9

    MODERN APPROACHES AND OPPORTUNITIES FOR THE EVALUATION OF CARDIOVASCULAR SYSTEM IN CHILDHOOD SPORTS by L. A. Balykova, S. A. Ivyansky, А. А. Shirokova, N. V. Shchyokina, N. А. Kalabkin

    Published 2015-10-01

    The article focuses on the modern approaches to evaluation of stress- induced changes in cardiovascular system in young people, regularly participating in sports. The problem of early and achievable diagnostics is highlighted, as by the experience of some abroad experts. Based upon literary data on...

    Full description

    Get full text
    Article
  10. 10

    Experience of the Tocilizumab Application in Systemic Onset Juvenile Arthritis by A. V. Krasnopol’skaja, O. N. Soldatova, E. S. Samoshkina, N. V. Shekina, L. A. Balykova

    Published 2015-11-01

    The article provides information on the unfavourable course of systemic onset juvenile arthritis, resistant to immunosuppressive therapy with methotrexate in combination with cyclosporine, and pulse therapy with methylprednisolone and methotrexate. We describe the successful use of genetically engin...

    Full description

    Get full text
    Article
  11. 11

    EXPERIENCE OF DESOXIRIBONUCLEATE SODIUM IMMUNOMODULATOR APPLICATION IN TREATMENT FOR REACTIVE ARTHRITIS OF CHLAMYDIA AETIOLOGY AMONG CHILDREN by L.A. Balykova, I.A. Markelova, S.V. Rodionova, T.I. Kornilova, O.V. Ferrapontova

    Published 2007-09-01

    Researchers compared efficacy of the conventional therapy (oilment with non steriod anti-inflammatory medication, diclofena sodium and azithromycin) among children with reactive arthritis of Chlamydia etiology and treatment with introduction of gluccosaminilmuramildi peptide and desoxiribonucleate s...

    Full description

    Get full text
    Article
  12. 12

    EXPERIENCE OF ABATACEPT TREATMENT IN A PATIENT WITH SEROPOSITIVE POLYARTHRITIS FROM RISK GROUP OF TUBERCULOSIS INFECTION by L. A. Balykova, N. V. Shchekina, A. V. Krasnopol’skaya, T. I. Kornilova, N. A. Os'kina

    Published 2013-12-01

    A short review on modern views on abatacept usage in treatment of juvenile idiopathic arthritis is shown in this article with highlighting of the high safety of this drug in accordance with severe opportunistic infections, including tuberculosis. The authors also discuss possibility of its usage in...

    Full description

    Get full text
    Article
  13. 13

    FOLLOW-UP OF METHOTREXATE EFFECTIVENESS IN A PATIENT WITH JUVENILE POLYARTHRITIS by L. A. Balykova, O. M. Soldatov, N. V. Shchekina, A. V. Krasnopol'skaya, A. N. Os'kina

    Published 2014-07-01

    The article presents a short review of the current notion of the leading role methotrexate in treatment of most clinical variants ofjuvenile idiopathic arthritis. The authors demonstrate that methotrexate is a “gold standard” of antirheumatic therapy and the key disease-modifying drug of pediatric r...

    Full description

    Get full text
    Article
  14. 14

    METABOLIC CARDIOPROTECTOR THERAPY IN PEDIATRIC SPORTS MEDICINE by L. A. Balykova, S. A. Ivyanskyi, N. I. Urzyaeva, V. P. Balashov, N. V. Ivyanskaya, N. V. Shchekina

    Published 2011-10-01

    Our previous studies have demonstrated the importance of early diagnostics and treatment of pathological cardiac transformations in young athletes. The present pilot clinical study is focused on cardioprotective effects of 2-ethyl-6-methyl-3-oxy-pyridine succinate (“Mexicor”, EcoPharmInvest) in youn...

    Full description

    Get full text
    Article
  15. 15

    EFFICACY AND SAFETY OF SOME ETIOTROPIC THERAPEUTIC SCHEMES FOR TREATING PATIENTS WITH NOVEL CORONAVIRUS INFECTION (COVID-19) by L. A. Balykova, V. F. Pavelkina, N. V. Shmyreva, N. A. Pyataev, N. M. Selezneva, O. I. Shepeleva, R. Z. Almyasheva

    Published 2020-12-01

    The aim of the study is to assess the efficacy and safety of the Favipiravir (Areplivir) drug, compared to the standard etiotropic therapy in the patients hospitalized with COVID-19.Material and methods. The research was conducted as a part of an open, randomized, multicenter comparative study of th...

    Full description

    Get full text
    Article
  16. 16

    The role of inducible NO-synthase isoform in stress-protective activity of antioxidant ethylmethylhydroxypyridine succinate by V. P. Balashov, L. D. Smirnov, L. A. Balykova, N. G. Gerasimova, I. A. Markelova, R. P. Kruglyakov, E. V. Talanova

    Published 2007-04-01

    The authors analyzed NO-synthase expression in white mice exposed to chronic immobilization stress and receiving intraperitoneal 2-ethyl-6-methyl-3-hydroxypyridine succinate (EMHPS). Immune-hystochemical analysis of left ventricular myocardium was performed by standard method, with primary inducible...

    Full description

    Get full text
    Article
  17. 17

    CURRENT ASPECTS OF ETIOTROPIC COVID-19 THERAPY by D. N. Zemskov, L. A. Balykova, O. A. Radaeva, K. Ya. Zaslavskaya, P. A. Bely, E. V. Semenova, M. V. Shirmankina, K. N. Koryanova

    Published 2022-12-01

    Since the beginning of the pandemic, repeated attempts have been made to develop etiotropic therapy for a novel coronavirus infection. Hydroxychloroquine, lopinavir/ritonavir, etc. derivatives were used as antiviral agents, however, they demonstrated a low efficiency and an insufficient safety. In t...

    Full description

    Get full text
    Article
  18. 18

    The effectiveness of liposomal doxorubicin hydrochloride in combination with cyclophosphan in the treatment of breast cancer in an experiment by L. A. Balykova, V. I. Inchina, T. V. Tarasova, L. M. Mosina, E. N. Gvozdikova, D. A. Khaydar, G. I. Myandina, S. M. Ryzhakin, I. V. Saushev

    Published 2021-12-01

    Purpose of the study. To evaluate the antitumor efficacy of liposomal doxorubicin hydrochloride in combination with tamoxifen in the treatment of breast cancer.Materials and methods. The study included mongrel white rats (n = 30). A model of carcinogenesis (Walker 256 tumors) was created for all ani...

    Full description

    Get full text
    Article
  19. 19

    STUDY OF CLINICAL AND PATHOGENETIC EFFECTS OF ANTI-VIRAL DRUG BASED ON FAVIPIRAVIR IN COMORBID PATIENTS WITH COVID-19 AT THE OUTPATIENT STAGE OF TREATMENT by L. A. Balykova, O. A. Radaeva, K. Ya. Zaslavskaya, Yu. A. Kostina, M. S. Iskandyarova, E. V. Negodnova, V. V. Eremeev, L. F. Sabirov, E. V. Semeleva

    Published 2021-12-01

    In many ways, arterial hypertension and obesity determine the likelihood of a severe course and lethal outcomes in COVID-19. This fact justifies the expediency of an early use of drugs with a direct antiviral action, the analysis of their efficacy not only in the acute, but also in the postcovid per...

    Full description

    Get full text
    Article
  20. 20

    Regeneration of an infected skin wound under conditions of experimental steroid hyperglycemia by L. A. Balykova, V. I. Inchina, T. V. Tarasova, D. A. Khaydar, L. M. Mosina, I. V. Saushev, A. V. Kuchuk, A. Mutvakel, I. V. Begoulov, R. S. Tarasov, P. V. Ageev, D. S. Ovchenkov

    Published 2023-03-01

    Purpose. To evaluate the regeneration of an infected skin wound in experimental steroid hyperglycemia in rats.Materials and methods. Regeneration of an infected rat skin wound (n = 30) was evaluated on the background of steroid hyperglycemia. Depending on the type of wound surface treatment, all obs...

    Full description

    Get full text
    Article